Cytek Biosciences, Inc.

NASDAQ:CTKB

4.2 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -6.02-12.1482.4843.02719.411-16.827
Depreciation & Amortization 10.499.235.6591.2420.6030.309
Deferred Income Tax -2.886000.4481.7440
Stock Based Compensation 26.84822.04816.5956.5860.6110.269
Change In Working Capital 0-10.509-39.928-8.646-7.5361.158
Accounts Receivables -5.428-7.332-19.744-12.3670.334-12.612
Inventory 14.7554.286-17.653-7.068-5.704-14.614
Accounts Payables 2.582-1.7841.862-0.256-0.0551.213
Other Working Capital 0-5.679-4.39311.045-2.11127.171
Other Non Cash Items -3.053-3.342.9591.9730.3231.344
Operating Cash Flow 25.3795.281-12.2314.6315.156-13.747
Investing Activities:
Investments In Property Plant And Equipment -3.525-4.648-9.868-4.364-1.547-0.973
Acquisitions Net -0.471-45.1320-16.62900
Purchases Of Investments -274.062-175.935-46.041000
Sales Maturities Of Investments 1951320000
Other Investing Activites 0.084-0.179-46.1610.37100
Investing Cash Flow -82.974-93.894-55.909-20.993-1.547-0.973
Financing Activities:
Debt Repayment 3.624-0.5652.93302.7720
Common Stock Issued 001.204215.689119.8350.093
Common Stock Repurchased -21.611-44.151-0.209000
Dividends Paid 000000
Other Financing Activities 2.1652.9042.58213.559239.5010.093
Financing Cash Flow -15.822-41.8125.513213.559122.6070.093
Other Information:
Effect Of Forex Changes On Cash 4.532-1.445-2.4911.303-0.587-0.033
Net Change In Cash -68.885-131.87-65.118198.499135.629-14.66
Cash At End Of Period 98.745167.63299.5364.618166.11930.49